Status: Recruiting
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Participants needed: 405
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Jukka PutaalaUpdated: Mar 20, 2025Locations: 4
Eligibility criteria
Ischemic stroke or transient ischemic attack (ABCD2 score ≥3) [+3]
Known high-risk source of cardioembolism [+5]